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ABSTRACT
The transcription factor Pax7 plays a key role during embryonic myogenesis and in adult organisms in that
it sustains the proper function of satellite cells, which serve as adult skeletal muscle stem cells. Recently
we have shown that lack of Pax7 does not prevent the myogenic differentiation of pluripotent stem cells.
In the current work we show that the absence of functional Pax7 in differentiating embryonic stem cells
modulates cell cycle facilitating their proliferation. Surprisingly, deregulation of Pax7 function also
positively impacts at the proliferation of mouse embryonic ﬁbroblasts. Such phenotypes seem to be
executed by modulating the expression of positive cell cycle regulators, such as cyclin E.
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Introduction
Embryonic Stem Cells (ESCs) are pluripotent cells that when
cultured under appropriate conditions retain the ability to self-
renew their population as well as to differentiate into any given
tissue. This characteristics makes them a perfect tool in develop-
mental biology and regenerative medicine studies. Developmental
biology takes advantage of the methods of ESC genetic modiﬁca-
tions and their in vitro as well as in vivo differentiation. Impor-
tantly, analyzes of differentiating ESCs are the prerequisite step
for the development of therapies involving stem cells which
could be used as a treatment for many degenerative diseases,
such as muscular dystrophies. In this context the role of crucial
regulators of differentiation as well as impact of the culture con-
ditions are essential issues in the studies involving ESCs.1,2
Many studies focusing at the mechanisms of ESCmyogenic dif-
ferentiation took advantage of genetically modiﬁed ESCs, such as
those lacking functional genes encoding myogenic regulatory fac-
tors (MRFs), e.g. myogenin,3 or structural proteins, e.g., desmin.4
Such approach allowed to prove that these genes are essential for
myogenic differentiation of ESCs. Our own study showed that
myogenic differentiation of ESCs can occur without functional
Pax7 gene,5 i.e. crucial regulator of both embryonic myogenesis
and maintenance of satellite cells in adult skeletal muscles.6 In the
same study we showed that differentiation of ESCs lacking func-
tional Pax7 resulted in the higher number of myoblasts, as
compared to wild-type cells. Our observation suggested that in dif-
ferentiating ESCs Pax7 acts as a cell cycle regulator.
In adult organisms Pax7 is involved in the regulation of the
balance between self-renewal and differentiation of the acti-
vated satellite cells.7 It is expressed in proliferating myoblasts
and downregulated when they differentiate into myotubes.8
Overexpression of Pax7 increases the proliferation of in vitro
cultured myoblasts.9 However, other data documented that
overexpression of Pax7 in MM14 myoblasts inhibits the cell
cycle.10 Pax7 was shown to induce the expression of genes
such as Inhibitor of differentiation 3 (Id3),11 known to prevent
MyoD expression and to inhibit apoptosis in quiescent satel-
lite cells.10,12 Myoblasts lacking MyoD, similarly to quiescent
satellite cells, express anti-apoptotic factors, such as Bcl-2 and
Bcl-xl.13 Interestingly, expression of dominant negative form
of Pax7 resulted in the increased proportion of myoblasts in S
phase. However, at the same time the number of cells per col-
ony of in vitro cultured primary myoblasts decreased suggest-
ing that in the absence of Pax7 G1 cells are lost most
probably via apoptosis.14 Importantly, in the absence of func-
tional Pax7 gene the number of satellite cells decreases dra-
matically after birth in mouse muscles.14,15 Taking together,
the inﬂuence of Pax7 on the regulation of proliferation and
apoptosis of satellite cells and myoblasts is unquestionable.
However, its participation in the cell cycle regulation is still
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less understood when compared to such myogenic regulators
like for example MyoD.
MyoD was shown to induce expression of cell cycle suppres-
sor gene encoding pRb protein.16 Active form of pRb results in
the dissociation of MyoD from histone deacetylase Hdac-1
what induces expression of its target genes,17 such as the one
encoding cell cycle inhibitor p21cip1.18 Interestingly, MyoD act-
ing together with pRb decreases expression of cyclin D1,
another positive cell cycle regulator, preventing cell prolifera-
tion.19 Myogenic differentiation is also associated with the
increase in the levels of other cell cycle inhibitors – p27cip2 and
p57kip2 20 (for the review see ref.21).
The role of Pax7 in ESCs was studied by silencing its
expression using siRNA what led to the decrease in the levels
of mRNAs encoding MyoD, Myf-5, and desmin.22 However,
in differentiating ESCs lacking functional Pax7 gene expres-
sion of these and other factors, e.g. Pax3, M-cadherin or
MyHC, was not affected.5 Interestingly, in these mutant cells
the levels of microRNAs, such as miR-133a was modiﬁed,
suggesting that the regulation of ESC proliferation and/or
differentiation may occur at the posttranscriptional level.
Importantly, ESCs lacking Pax7 were able to turn into myo-
blasts and initiate myotube formation in EB outgrowths.5
These observations were consistent with the data showing
that mice lacking functional Pax7 do form skeletal muscles,
although, of lower mass and containing limited number of
satellite cells.8,23 However, the role of Pax7 in the regulation
of proliferation and apoptosis of ESCs induced to undergo
myogenic differentiation in vitro was not studied. For this
reason, we took advantage of cells in that function of Pax7
was ablated. Since cell cycle machinery is speciﬁcally adjusted
in ESCs (for the review see ref.21,24) we also investigated the
inﬂuence of Pax7 ablation on cell cycle in well-characterized,
“standard” cells, i.e., mouse embryonic ﬁbroblasts (MEFs).
By doing so we were able to compare the impact of the Pax7
at the proliferation and apoptosis of differentiating stem cells
as well as, non-myogenic cells, non stem cells, i.e. ﬁbroblasts.
The role of Pax7 in MEFs has not been studied and docu-
mented so far.
Results
Transcription proﬁling of cells lacking functional Pax7
ESCs lacking functional Pax7 (Pax7ko) are able to undergo
myogenic differentiation, i.e., form myoblasts as well as initiate
formation of myotubes, similarly to control, i.e. Pax7wt cells.5
In our previous study to induce ESC differentiation we gener-
ated embryoid bodies (EBs), i.e., tridimensional structures reca-
pitulating early stages of embryonic development.25,26 By using
this technique, we showed that cultures of Pax7ko ESCs
resulted in the higher number of myoblasts as compared to
control ones. To trace the background of this phenomenon we
analyzed the expression of genes regulating myogenic differen-
tiation. Microarray analysis comparing Pax7wt and Pax7ko
ESCs did not reveal any signiﬁcant differences in the levels of
mRNAs encoding myogenic factors, such as MyoD, Myf5 or
myogenin. This comparison, however, revealed many differen-
tially expressed genes.5 Among them were transcripts encoding
cell cycle regulators which upregulation could result in the gen-
eration of higher numbers of muscle progenitor cells, and thus,
higher number of myoblasts. For this reason, we focused at the
cell cycle progression in differentiating ESCs. In addition, we
decided to assess the function of Pax7 in mouse embryonic
ﬁbroblasts (MEFs) serving as an example of non-myogenic and
non-stem cells, in that the function of Pax7 was not reported so
far. However, this protein was shown by us to be present in
asynchronously proliferating wild-type MEFs (Fig. 1A and B).
To our surprise performed analyzes revealed Pax7-related phe-
notype in case of both, ESCs and also MEFs.
First, we focused at the global gene expression proﬁles of
undifferentiated ESCs, EBs at day 7 of culture, and EB out-
growths (EBOs) at day 21 of culture (Fig. 2), as well as in asyn-
chronously proliferating MEFs. For each cell type we analyzed
one Pax7wt as well as one Pax7ko line and compared RNA
samples obtained from 3 independent experiments. Performed
comparisons revealed many differences in ESC (database access
available in NCBI’s Gene Expression Omnibus GSE66483) and
MEF transcriptomes (database access available in NCBI’s Gene
Expression Omnibus GSE80658). As mentioned above, among
Figure 1. Pax7 in mouse embryonic ﬁbroblasts. (A). Western blotting analysis of Pax7 in whole 13.5-day-old embryo (Emb) and asynchronously dividing MEFs; (B). Locali-
zation of Pax7 (green) and nuclei (red) in MEFs; bar 50 mm.
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the genes which expression differed between cells expressing
and lacking functional Pax7 we identiﬁed ones encoding pro-
teins controlling cell cycle. Gene Ontology analysis of signiﬁ-
cantly expressed genes showed that in differentiating ESCs out
of 1248 biological processes 34 were related to the cell cycle
(Fig. 3A, Table S1). The same analysis done for asynchronously
dividing MEFs revealed that 8 processes out of 765 that were
singled out were related to the cell cycle (Fig. 3A, Table S2).
Enrichment score included into the supplementary tables rep-
resents the level of signiﬁcance, i.e. the higher the enrichment
score, the more given GO functional group is over-represented
in the gene list.
In pluripotent Pax7wt and Pax7ko ESCs, as well as in
cells analyzed at day 7 of differentiation, the levels of the
majority of the cell cycle related transcripts did not signiﬁ-
cantly differ. However, some of the genes were upregulated
in Pax7ko cells. These were Ccng1 encoding cyclin G1,
which is a direct target of p53, also involved in the regula-
tion of differentiation. The most profound differences, how-
ever, were observed at day 21 of differentiation, i.e., when
the cells cease to proliferate (Fig. 3B). At this time point
Pax7ko cells were characterized by lower levels of such
transcripts as Cdkn1c encoding Cdk inhibitor – p57kip2,
Dusp9 encoding phosphatase inactivating MAP kinase and
impacting proliferation, and Dap (Death associated protein)
which acts as a positive mediator of cell death.27 Levels of
several mRNAs encoding positive regulators of cell cycle
were higher in Pax7ko ESCs. Among them were Polo-like
kinase (Plk1), cyclins E1 (Ccne1), A2 (Ccna2), B2 (Ccnb2),
proteins of Mcm (minichromosome maintenance deﬁcient)
family, subunit of DNA polimerase delta (Pold2), and sub-
unit of anaphase promoting complex (Anapc1) (Fig. 3B).
Similar analysis carried out for asynchronously proliferating
MEFs, which we chosen as control non-myogenic cells, delivered
surprising results. During embryonic development Pax7 was never
showed to be involved in the function of cells other than neural
and myogenic ones. In adults, except satellite cells, it was also
detected in testes.28,29Microarray analyses performed by us showed
that inMEFs lacking functional Pax7 the levels of many transcripts
differed as compared to Pax7wt cells. Thus, Pax7ko MEFs showed,
similarly to Pax7ko ESCs, lower levels of Cdkn1c and Dap tran-
scripts (Fig. 3B). Next, the levels of mRNAs encoding Ccng1 and
Ccne1 were higher in Pax7ko MEFs, again similarly to ESCs of the
same genotype (21 day of culture). Such data suggested increased
Figure 2. Schematic diagram of the protocol used to induce the differentiation of ESCs (see Materials and Methods); EBs – embryoid bodies, EBOs – embryoid body out-
growths; time points when samples were collected for analysis are indicated in black circles.
Figure 3. Analysis of expression of genes involved in regulation of cell cycle in both Pax7ko and Pax7wt ESCs and MEFs. (A). Gene Ontology analysis of sig-
niﬁcantly expressed genes in differentiating ESCs and asynchronously proliferating MEFs showing proportion of cell cycle related processes among all
others. List of the processes is presented in Tables S1 and S2; (B). Microarray analysis of the expression levels of transcripts that encoded cell cycle-associ-
ated proteins in undifferentiated ESCs and in EBs at day 7 and EBOs at day 21 of differentiation (left diagram) and asynchronously proliferating MEFs (right
diagram). For each cell type and genotype one cell line was analyzed. Each group included triplicate measurements. Blue color indicates low expression
and red color indicates high expression levels of transcripts. Genes which levels change similarly in differentiating ESCs and MEFs were marked in green.
All genes shown were selected from the database complete list presented in Czerwinska et al.5 and Table S3.
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proliferation ability of Pax7ko cells. However, at the same time we
noticed that in the absence of functional Pax7 both ESCs and
MEFs upregulated Casp3 and Pcbp4, i.e. the genes encoding factors
involved in the execution of apoptosis. Selected transcripts were
further analyzed using RT-qPCR in two Pax7wt and two Pax7ko
ESC lines as well as in three Pax7wt and three Pax7koMEF lines.
The levels of mRNAs encoding Ccnd1, Ccne1, Ccna2, Ccnb2,
Cdkn1a, Cdkn1b, Cdkn1c, as well as Plk1, Cdc34, and Mcm5
Figure 4. Analysis of factors involved in regulation of cell cycle in both Pax7ko and Pax7wt ESCs and MEFs. (A). RT-qPCR analysis of Ccnd1, Ccne1, Ccna2, Ccnb2, Cdkn1a,
Cdkn1b, Cdkn1c, Plk1, Cdc34, and Mcm5 transcript levels in undifferentiated ESCs, EBs at day 2, 7 and EB outgrowths at day 21 of differentiation, as well as asynchronously
dividing, quiescent and synchronously cycling MEFs. Data are shown as CT values, which were normalized against those of Actb mRNA level. Data are represented as the
percentage of expression observed in mouse embryos at day 13.5 of development. For each genotype 2 ESC and 3 MEF lines were analyzed, graphs represent the mean
values. P-values: <0.05,  <0.01, <0.001. (B). Western blotting analysis of cyclin E1 levels in ESCs, EBs at day 2 and 5, and EB outgrowths at day 14 of differentiation.
Probing with anti-Hsp90 antibody was used as a loading control. Graph represents optical density of cyclin E bands compared to density of Hsp90 bands (optical density
of Hsp90 was taken as 100 arbitrary units).
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were compared in non-differentiated ESCs, EBs at day 2, 7, as
well as EB outgrowths at day 21 of culture (Fig. 4A). In undif-
ferentiated ESCs only the expression of Mcm5 differed
between Pax7wt and Pax7ko cells – it was signiﬁcantly higher
in mutant cells. Next, Pax7ko ESCs expressed signiﬁcantly
higher level of mRNA encoding cyclin E1 (Ccne1), as com-
pared to wild-type control, but only at day 2 of differentiation.
Western blot analyzes conﬁrmed that level of cyclin E was the
highest in EBs at day 2 of differentiation, then dropped at day
5 and 14. In fact, at 14 day of differentiation it was absent in
Pax7wt cells while still detectable in Pax7ko ones. However,
the differences between Pax7wt and Pax7ko cells were rather
subtle (Fig. 4B). The levels of the other genes analyzed by
RT-qPCR did not signiﬁcantly differ between the cells of dif-
ferent genotypes.
Next, we analyzed 3 populations of MEFs: asynchronously
dividing, serum starved, i.e., quiescent cells, as well as synchro-
nized by serum-starvation proliferating ones. By doing so we
hoped to highlight the differences detectable in microarray ana-
lyzes of transcriptomes of asynchronously dividing cells. Syn-
chronously dividing Pax7ko MEFs were characterized by
higher levels of Ccne1 and Mcm5 transcripts, what resembled
the phenotype of ESCs of the same genotype (Fig. 4A and B).
Importantly, the expression of genes encoding Cdk inhibitor,
i.e. Cdk1c was lower in serum-starved Pax7ko MEFs, as com-
pared to Pax7wt ones.
Figure 5. Analysis of proliferation of both Pax7ko and Pax7wt ESCs. (A). The proportion of cells (median values) expressing Ki-67 in ESCs colonies (left diagram) and in EB
outgrowths at 14 day of differentiation (right diagram). P-value: <0.01. (B). Localization of Ki-67 (green) and nuclei (red) in ESCs (left panel) and EB outgrowths at
14 day (right panel); bar 50 mm. (C). The number of cells (median values) per EB at 2 (left diagram) and 5 (right diagram) days of culture. P-value: <0.05. (D). The propor-
tion of ESCs and cells building EBs retaining ﬂuorescence 48 h after pulse labeling with CFSE. Schematic diagram (left panel) showing the intensity of ﬂuorescence of cells
that did not divide (black), underwent few divisions (white), and cells that were nontreated with CFSE and represent ones that divided vigorously, underwent multiple
divisions and lost CFSE labeling (gray). Proportion of ESCs and cells building EBs characterized by various ﬂuorescence intensity (right panel). (E). The proportion of cells
in G1, S, and G2/M phase of cell cycle among undifferentiated ESCs and cells in EBs at 2 and 5 d of culture. For each genotype 3 cell lines were analyzed, graphs represent
the mean values.
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Proliferation of cells lacking functional Pax7
mRNA analyses showed that Pax7ko ESCs express higher levels
of G1 phase cyclins and lower levels of Cdk inhibitors. Thus,
we examined the proliferation and cell cycle proﬁles of ESCs
and MEFs (3 cell lines for each genotype). We analyzed non-
differentiating ESCs and EBs at day 2 and 5, as well as EB out-
growths at day 14 of culture. Proportion of undifferentiated
ESCs expressing Ki-67, i.e., marker of cycling cells,30 was the
same in case of Pax7wt and Pax7ko ESC lines, i.e. reached 93%
(Fig. 5A and B). Interestingly, EBs generated from Pax7ko
ESCs were larger than those obtained from Pax7wt ESCs, both
at day 2 and 5 of culture. By disaggregating EBs and counting
cells we showed that Pax7ko EBs were composed of more cells
than Pax7wt EBs (Fig. 5C). At day 5 of culture the difference
was signiﬁcant (p D 0.0297). On the other hand, at day 14 of
culture number of proliferating cells, i.e., expressing Ki-67, was
signiﬁcantly higher (p < 0.0001) in Pax7wt, as compared to
Pax7ko EB outgrowths (24% vs. 16%, Fig. 5A and B). This phe-
nomenon most probably reﬂects the fact that the Pax7ko cells
more readily start to differentiate as compared to wild-type
ones.5
Assessment of the proliferation dynamics was done using
CFSE labeling method which relies on the pulse labeling of cells
with ﬂuorescent dye, i.e. CFSE, followed by FACS analyzes after
further in vitro culture. Since each cell division leads to the
dilution of incorporated CFSE proliferating cells are character-
ized by the decreasing ﬂuorescence intensity. Thus, cells that
did not divide appear as highly ﬂuorescent (Fig. 5D, marked in
black), those that underwent few divisions are characterized by
decreased ﬂuorescence (Fig. 5D, marked in white), and ﬁnally
in those intensively dividing ﬂuorescence is undetectable
(Fig. 5D, marked in gray). Using such method we showed that
pluripotent Pax7wt and Pax7ko ESCs did not differ in their
proliferation rate during 48 h of culture. However, Pax7ko cells
building EBs divided more vigorously, as compared to Pax7wt
ones (Fig. 5D).
Analysis of cell cycle proﬁle with propidium iodide showed
that the highest proportion of cells in S-phase was observed at
day 2 of differentiation. At day 5 of differentiation the propor-
tion of Pax7wt cells in G1 increased and the population of cells
in G2/M dropped. Importantly, the proportion of cells in vari-
ous cell cycle phases did not differ between Pax7wt and Pax7ko
ESCs at all analyzed stages of differentiation (Fig. 5E).
Analysis of CFSE labeling revealed that population of asynchro-
nously dividing Pax7ko MEFs contained more dividing cells
(Fig. 6A). After 72 h of culture following CFSE pulse fewer Pax7ko
MEFs did not divide, as compared to Pax7wt ones. To more pre-
cisely follow the cell cycle progression we analyzed serum starved
and synchronously dividingMEFs. Proportion of Ki-67 expressing,
i.e., cycling cells, in population of serum-starved MEFs was higher
in the population of Pax7wt MEFs, as compared to Pax7ko ones
(30% vs. 21%). However, this difference was not statistically signiﬁ-
cant due to high deviation of obtained results (Fig. 6B). Interest-
ingly, analysis of synchronously proliferating MEFs (i.e. 18 h after
serum stimulation) revealed that signiﬁcantly more Pax7ko cells (p
D 0.0127) reentered the cell cycle and expressed Ki-67, as com-
pared to Pax7wt ones (55% vs. 44%) (Fig. 6 B and C). Proportion
of G1, S, and G2/M cells among serum-starvedMEFs did not differ
between Pax7wt and Pax7ko cell lines (Fig. 6D). Serum re-activa-
tion increased the proportion of MEFs in S-phase to 9% and 11%
in Pax7wt and Pax7ko MEF populations, respectively. Interest-
ingly, the proportion of cells in G1 was signiﬁcantly (p < 0.0001)
lower in the population of Pax7ko than in Pax7wt MEFs (32% vs.
45%). Consequently, the proportion of G2/M cells was signiﬁcantly
higher (p < 0.0001) in case of Pax7ko as compared to Pax7wt
MEFs (57% vs. 46%) (Fig. 6D). High fraction of G1 and low frac-
tion of S phase suggested that these cells were in the process of cell
cycle re-entry.
Apoptosis of cells lacking functional Pax7
To evaluate apoptosis rate of ESCs and MEFs lacking functional
Pax7 we established the proportion of the cells expressing
Figure 6. Analysis of proliferation of both Pax7ko and Pax7wt MEFs. (A). Proportion of MEFs characterized by various CFSE ﬂuorescence intensity. (B). The proportion of
cells (median values) expressing Ki-67 in quiescent (left diagram) and cycling (right diagram) MEFs. P-value: <0.05. (C). Localization of Ki-67 (green) and nuclei (red) in
cycling MEFs; bar 50 mm. (D). The proportion of cells in G1, S, and G2/M phase of cell cycle among quiescent and cycling MEFs. For each genotype 3 cell lines were ana-
lyzed, graphs represent the mean values. P-value:  <0.0001.
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phosphorylated isoform of histone H2A.X (g-H2A.X), i.e., the
marker of apoptotic cells.31 Again we analyzed 3 lines of ESCs
and MEFs for each genotype.
We did not evaluate the proportion of cells expressing g-H2A.
X in undifferentiated ESCs as this isoform is abundant in such
cells and its presence does not correlate with apoptosis.32,33 Inter-
estingly, at 14 day of differentiation the fraction of apoptotic cells
was signiﬁcantly higher (p D 0.0004) in Pax7wt EB outgrowths,
as compared to Pax7ko ones (11% vs. 7%, Fig. 7A and B). The
ratio of apoptotic MEFs was similar in both Pax7wt and Pax7ko
serum-starved MEFs, reaching 14% (Fig. 7C and D) and did not
change after serum activation, i.e. 14% of Pax7wt and 18% of
Pax7koMEFs expressed g-H2A.X (Fig. 7C and D).
Discussion
Cell cycle progression is regulated by the universal factors that
operate in every dividing cell, regardless of its type and origin (for
the review see refs.21,34,35). However, “standard” cell cycle
machinery is custom-tuned in many types of cells, such as plurip-
otent, differentiating or aging ones. Among the cells which mech-
anisms regulating proliferation are not “custom-modiﬁed” are
mouse embryonic ﬁbroblasts which for this reason are used in
numerous studies focusing on the cell cycle regulation. On the
other hand, embryonic stem cells are the example of unique cells
which cell cycle regulation is specially adjusted (for the review see
ref.24). These cells are characterized by the ability to self-renew
and by rapid cell cycles during which function of pRb-Cdk/cyclin
D/p16 axis is restricted.36,37 Expression of cyclins D is low and
Cdk4 activity is either faint, or if detectable, as in case of Cdk4-
cyclin D3 complex, resistant to p16ink4 inhibition.36,38,39 Such
restrictions result in the constitutive activation of E2F transcrip-
tion factors and, as a result, in constant expression of its target
genes, such as cyclin E.40 Among the factors which follow
“standard” cell cycle pattern are for example cyclin A,41 cyclin B1
or Cdk1.40 Induction of ESC differentiation leads to the resurrec-
tion of canonical mechanisms, i.e., increase in the cyclins D levels,
Cdk4 activity, and in consequence oscillatory regulation of pRb
and E2F activity.42,43 As differentiation progresses it is also
accompanied by other changes, such as rise in the levels of Cdk
inhibitors, i.e. p21cip1, p27cip2, and p57kip2, leading to the quies-
cence in case of terminally differentiated cells.
Among the factors involved in cell cycle regulation of differ-
entiating cells are the ones involved in the determination of cell
fate. For example, MyoD is well known interactor of pRb mak-
ing a bridge between cell cycle machinery and myogenic regula-
tors (for review see ref.21). During embryonic myogenesis Pax3
and Pax7 transcription factors play a crucial role in the speciﬁ-
cation of skeletal muscle precursor cells and also impact at the
cell cycle progression. Downregulation of Pax3 in the dermo-
myotome of chick embryos caused cell cycle arrest of proliferat-
ing muscle precursor cells.44 Similarly, lack of Pax3 led to the
drop in the number of precursor cells in dermomyotome of
mouse embryo.45,46 Pax3 activity is also crucial for the survival
of precursor cells migrating from the dermomyotome to the
limb buds.46-48 Function of Pax7 in the cell cycle regulation is
less obvious, however, chromosomal translocation and fusion
of DNA binding domain of either Pax3 or Pax7 genes with
transcriptional activation domain of FOXO1a (FKHR) leads to
the development of rhabdomyosarcomas.49 Overexpression of
Pax3 or Pax7 in in vitro cultured myoblasts increased their pro-
liferation.9 In vitro cultured Pax7-null myoblasts were charac-
terized by decrease in proliferation and overexpression of
dominant negative Pax7 signiﬁcantly increased apoptosis in
these cells.14 Next, mice expressing nonfunctional Pax7 devel-
oped skeletal muscles, though muscle mass and diameter of
myoﬁbers were smaller in comparison to wild-type litter-
mates.8,23 Also in vitro cultured myoblasts lacking functional
Figure 7. Analysis of apoptosis rate of both Pax7ko and Pax7wt ESCs and MEFs. (A). The proportion of cells expressing g-H2A.X in EB outgrowths at 14 day of differentia-
tion. P-value: <0.001. (B). Localization of g-H2A.X (green) and nuclei (red) in EB outgrowths at 14 day of in vitro culture; bar 50 mm. (C). The proportion of cells express-
ing g-H2A.X in quiescent (left diagram) and cycling (right diagram) MEFs. (D). Localization of g-H2A.X (green) and nuclei (red) in cycling MEFs; bar 50 mm. For each cell
type and genotype 3 cell lines were analyzed, graphs represent the median values.
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Pax7 gene form fewer and smaller myotubes.15 What is impor-
tant, Pax7ko mice die within 2 weeks after birth and during
this period the number of satellite cells found in their muscles
diminishes rapidly.15,50
Identiﬁcation of Pax7 transcription factor targets in E16
mouse embryos revealed several genes involved in the regula-
tion of proliferation.51 Among them were genes positively
impacting cell proliferation, such as CntfR, receptor of
CNTF – a member of IL-6 family, which induces Jak/STAT
and Ras/MAPK signaling,52 Camk1d involved in calcium-cal-
modulin dependent signaling,53 as well as Frk which also regu-
lates cell cycle progression.54 None of these genes was identiﬁed
in our comparison of differentiating Pax7wt and Pax7ko ESCs
or proliferating MEFs. Microarray analyzes focusing at the dif-
ferentiating ESCs lacking functional Pax7 revealed, however,
that they are characterized by upregulated expression of several
genes involved in cell cycle regulation, e.g., cell cycle related sig-
naling pathways (Cdca7, Pten, Dusp4, Plk1), G1 and S phase
progression (Ccne1, Mcm5, Tfdp1, Anp32b), cell cycle-depen-
dent protein degradation (Skp1a, Huwe1, Cdc34, Trim37,
Anapc1), cell division (Ccnb2, Ckap2), or genes involved in the
regulation of apoptotic cell death (Casp3, Ddit4, Trp53), and
decreased levels of mRNAs encoding apoptosis related genes
Tnfsrf21, Dap. Further, RT-qPCR analyzes conﬁrmed that in
Pax7ko ESCs Ccne1 gene, encoding cyclin E1 that with Cdk2
regulates G1/S phase transition, was upregulated, but only at
the initial stages of in vitro differentiation. Both, cyclin E
mRNA and protein decreased at more advanced stages of EBs
and EB outgrowths culture. Differences in the levels of other
mRNAs analyzed using RT-qPCR technique were noticeable
but not statistically signiﬁcant. Nevertheless, these subtle
changes seems to impact at the proliferation of ESCs since in
EBs formed from Pax7ko cells we found more cells than in the
control ones. At day 5 of culture this difference was signiﬁcant,
suggesting that either more of these cells were cycling or cell
cycles were shorter. Next, at day 14 of culture, i.e., when the dif-
ferentiation is more advanced, Pax7ko EB outgrowths con-
tained less cycling cells, but most probably still expressing
higher levels of proliferation-promoting genes, as compared to
wild-type control. This may suggest that in the absence of func-
tional Pax7 ESCs progress to the “differentiation state” more
readily. Interestingly, at this stage Pax7ko EB outgrowths were
also characterized by the lower number of cells undergoing
apoptosis what may secure the higher number of myogenic
cells that we observed previously.5 This observation is, however,
not in line with the already available data showing that muscles
of mice lacking functional Pax7 contained apoptotic cells
whereas those of wild-type animals did not.14 Notion that satel-
lite cells die in the absence of Pax7 was further supported by
the observation that expression of dominant negative Pax7
gene leads to cell death in high proportion of cells (while
expression of dominant negative Pax3 has not such effect).14
Thus, it is possible that during ESCs differentiation lack of
functional Pax7 does not cause the increase in the apoptosis.
Pax7ko cells may execute apoptosis as effectively as wild-type
ones but also prematurely exit the cell cycle by forming myo-
tubes, when the Pax7wt cells still proliferate but not differenti-
ate. This is in agreement with our observation that Pax7ko EB
outgrowths contained more cells expressing MyoD.5
Surprisingly, results of our analyzes uncovered the differen-
ces at the level of cell cycle machinery in MEFs, i.e. the cells
in which – to our knowledge – Pax7 function has not been
assessed so far. In 2011 Amini-Nik et al.55 documented the
involvement of Pax7 expressing cells in the wound repair.
However, they suggested that the cells expressing Pax7 origi-
nated from satellite cells that adopted ﬁbrotic phenotype.
However, Pax7 expression in NIH3T3 ﬁbroblasts was also
documented by various vendors distributing anti-Pax7 anti-
bodies (e.g. Abcam, MerckMillipore) what, together with our
data, suggests that Pax7 is expressed also in cells other than
neuronal or muscle speciﬁc satellite cells. In fact, during recent
years its presence was also discovered in spermatogonia in
adult testes.28,29 The function of Pax7 in MEFs is supported
by our results showing that lack of functional Pax7 results in
the decrease of proportion of MEFs in G1 phase, increase of
proportion of MEFs expressing Ki-67 and being at G2/M tran-
sition. In Pax7ko MEFs, similarly to ESCs, we observed upre-
gulation in the level of mRNA encoding cyclin E1, again
indicating the relation between Pax7 and the regulation of at
least G1/S phase progression. We did not, however, notice any
differences in the number of apoptotic cells between Pax7wt
and Pax7ko cells. Thus, Pax7 is a factor regulating prolifera-
tion of both types of cells studied, i.e., unique mammalian
cells such as ESCs and “standard” mammalian cells such as
MEFs.
Materials and methods
Animal studies were approved by Local Ethics Committee No.
1 in Warsaw, Poland according to the European Union Direc-
tive on the approximation of laws, regulations and administra-
tive provisions of the Member States regarding the protection
of animals used for experimental and scientiﬁc purposes.56,57
All mice were raised on the premises and were maintained
under a 12 hours light/12 hours dark cycle. All analyses were
performed at least in 3 independent experiments.
Embryonic stem cells derivation and culture
Embryonic stem cells (ESCs) lacking functional Pax7 were
derived, genotyped, and analyzed as described previously.5
Medium for ESCs culture was composed of KnockOut
Dulbecco’s modiﬁed Eagle’s Medium (KnockOut DMEM,
Gibco) supplemented with 15% heat-inactivated fetal bovine
serum (FBS, Performance Plus, Gibco) with addition of nones-
sential amino acids (0.1 mM, Gibco), L-glutamine (2 mM,
Gibco), b-mercaptoethanol (0.1 mM, Sigma-Aldrich), penicil-
lin and streptomycin (5000 units/ml each, Gibco), as well as
murine leukemia inhibitory factor (LIF, 1000 IU/ml, ESGRO,
Chemicon International). ESCs were cultured on feeder layer,
i.e. inactivated mouse embryonic ﬁbroblasts (MEFs) prepared
according to Robertson (also see below).58
In vitro differentiation of ESCs
Differentiation of ESCs was carried as described previously.5
Brieﬂy, ESCs cultured at the layer of inactivated MEFs were
detached with 0.05% trypsin-EDTA (Gibco). MEFs were
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separated by pre-plating, i.e., single cell suspension of ESCs and
MEFs was seeded onto gelatin-coated dish for 20 min to allow
MEFs to attach to the culture dish. Next, medium containing
ESCs only was collected and EBs were generated by placing of
800 ESCs in 30 ml drops of culture medium lacking LIF formed
at the culture dish covers, i.e. so called hanging drops culture
method was used (for the review see refs.26,59). After 2 days of
culture EBs were collected from hanging drops and cultured in
suspension for further 5 days (Fig. 1). During this period, cul-
ture medium was supplemented with retinoic acid (30 nM in
dimethylsulfoxide; Sigma-Aldrich) and 1% of supplement con-
sisting of insulin, transferrin, selenite (Gibco). At 7 day of cul-
ture EBs were plated onto coverslips (about 20 EBs per
coverslip) coated with gelatin (Sigma-Aldrich) to generate EB
outgrowths. Starting from day 10 of culture, EB outgrowths
were cultured in DMEM containing 20% heat-inactivated FBS,
penicillin and streptomycin. Next, the concentration of FBS in
culture medium was reduced to 10% (day 13) and 5% (day 14).
Starting from day 15 of culture medium composed of DMEM
and F12 (1:1) supplemented with 1% N2 (Gibco), penicillin
and streptomycin but lacking FBS was used. Culture media
were changed every 2–3 days. EBs and EB outgrowths were
analyzed at 2, 5, 7, 14, and 21 day of culture (Fig. 2).
Mouse embryonic ﬁbroblasts isolation and culture
Primary MEFs lacking functional Pax7 gene were derived from
13.5-day-old embryos obtained after crossing of F1 (C57Bl/6N £
129Sv) Pax7C/¡ females with the males of the same genetic back-
ground and genotype. Primary MEFs were cultured in DMEM
(with 4500 mg/l glucose, Gibco) supplemented with 10% of heat-
inactivated FBS (Gibco), penicillin and streptomycin. Genotyping
of MEFs was performed as previously described for ESCs.5 Brieﬂy,
heads of the embryos that served to isolateMEFs were incubated in
10% Chelex 100 (Bio-Rad) solution in deionized water, in 98C,
for 15 minutes. After centrifugation, supernatant containing DNA
was collected and 1ml of obtained solution was used for PCR anal-
ysis using RedTaq Ready Mix (Sigma-Aldrich) and primers
according to conditions described previously.23 PCR products were
separated in 1.5% agarose gel (Bio-Rad) and visualized with ethi-
dium bromide (1 mg/ml, Sigma-Aldrich). Agarose gels were ana-
lyzed with GelDoc 2000 (Bio-Rad) using Quantity One software
(Bio-Rad). Wild-type allele was represented by 200 bp and knock-
out allele by 600 bp band.23
Mouse embryonic ﬁbroblasts synchronization
MEFs were synchronized by 48-hour-long serum starvation,
i.e., culture in DMEM (containing 4500 mg/l glucose, Gibco)
supplemented with antibiotics, but lacking FBS. Afterwards,
MEFs were either collected for analysis, or cultured in DMEM
supplemented with 10% inactivated FBS. After an additional
18 hours of culture MEFs were collected for further analyses.
Preparation of feeder cells for ESC culture
Primary MEFs used as a feeder cells were derived from 13.5-
day-old embryos obtained after crossing of F1 (C57Bl/
6NxCBA/H) mice. Next, conﬂuent MEFs were treated with
mitomycin C (10 mg/ml, Sigma-Aldrich) for 2 h, stored in
¡80C, and plated on gelatin-coated dishes one day before the
plating of ESCs.
Isolation of mRNA and RT-qPCR
Total RNA was extracted from ESCs, EBs, and EB outgrowths
using High Pure RNA isolation kit (Roche) and from MEFs
using mirVana miRNA Isolation Kit (Ambion), according to
the manufacturer’s instructions. Reverse transcription was per-
formed using 0.5 mg of RNA and RevertAid First Strand
cDNA Synthesis Kit (Thermo Fisher Scientiﬁc) according to
manufacturer’s instruction. Next, qPCR analysis was performed
using LightCycler 96 instrument (Roche), TaqMan Gene
Expression Master Mix (Life Technologies), and speciﬁc Taq-
Man probes: Mm00432359_m1 (Ccnd1), Mm00432367_m1
(Ccne1), Mm00438066_m1 (Ccna2), Mm01171453_m1
(Ccnb2), Mm01243769_m1 (Mcm5), Mm00775040_gH
(Cdc34), Mm00440924_g1 (Plk1), Mm04205640_g1 (Cdkn1a),
Mm00438168_m1 (Cdkn1b), Mm01272135_g1 (Cdkn1c),
Mm01205647_g1 (Actb). Data were collected and analyzed
with LightCycler 96 SW1.1 software (Roche). Ddct analysis was
performed according to Livak.60
Microarray analysis
For microarray analyses total RNA was isolated from undifferenti-
ated ESCs, EBs (day 7 of culture), EB outgrowths (day 21 of culture)
and asynchronously proliferating MEFs. For each type of cell cul-
tures samples were collected from 4 independent experiments car-
ried out at the same time. RNA was isolated using High Pure RNA
isolation kit. Next, its integrity was checked with 2100 Bioanalyzer
(Agilent Technologies) using RNA 6000 NAno LAb Chip kit (Agi-
lent Technologies). All RNA samples had integrity number above
8.5. For target preparationAmbionWTExpressionKit (Ambion)
was used. Sense-strand cDNA after fragmentation was labeled
usingGeneChipWTTerminal Labeling (Affymetrix) and hybrid-
ized onto Affymetrix Mouse Gene 2.1 ST Array Strip, according
to the manufacturer’s instructions. Following hybridization the
arrays were washed and stained using Affymetrix GeneAtlas ﬂuidic
station and scanned on Affymetrix GeneAtlas Imaging station. The
intensity signals for each of the probe sets were written by into the
“.cel ﬁles” and were imported into the Partek Genomic Suite v6.6
software with the use of RMA (Robust Multiarray Averaging).
Background correction was applied based on the global distribu-
tion of the PM (perfect match) probe intensities and the afﬁnity for
each of the probes (based on their sequences) was calculated during
import. Further, the probe intensities were quantile normalized,61
log2 transformed and median polish summarization to each of the
probe sets was applied. Then the quality check was performed, e.g.,
Principal Component Analysis, in order to identify outliers and
artifacts on the microarray. Afterwards the Analysis of Variance
(ANOVA) allowed to create lists of signiﬁcantly and differentially
expressed genes between the biological variants. The selected lists
were subjected to cluster analysis with the use of unsupervised
Hierarchical Clustering algorithm in order to ﬁnd genes and sam-
ples with similar proﬁles. Clusters were calculated on raw intensi-
ties that were standardized, i.e. shifted to mean of 0 and scaled to
standard deviation of 1. Further, the color scale among all heat
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maps was set to the range of ¡2 to 2 in order to equalize dynamic
ranges of all the intensity plots. The data coming from ESCs analy-
ses have been deposited in NCBI’s Gene Expression Omnibus and
are accessible through GEO Series accession numbers: GSE66483
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accDGSE66483)
and as a supplementary tables in Czerwinska et al.5 Data com-
ing from MEFs analyses have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series
accession number GSE80658 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?accDGSE80658). Gene Ontology analysis
was performed with the use of Partek Genomic Suite v6.6 soft-
ware. Enrichment score (ES) represents the level of signiﬁcance;
the higher the enrichment score, the more a given GO func-
tional group is over-represented in the gene list. The enrich-
ment score was calculated using a chi-square test comparing
the proportion of the gene list in a group to the proportion of
the background in the group. ES > 1 means that the functional
category is overexpressed, ES => 3 represents a signiﬁcant
overexpression (P-val < 0.05).
Propidium iodide staining and ﬂow cytometry analysis
ESCs after pre-plating, EBs collected at day 2 or 5 of cul-
ture, and 2 types of MEFs, i.e., serum starved or serum
starved for 48 h and then cultured for 18 hours in DMEM
containing FBS, were disaggregated using trypsin-EDTA.
Next, cells were washed twice in PBS (phosphate-buffered
saline) and ﬁxed in 70% cold ethanol (Chempur). After
another 2 washes in PBS, cells were suspended in PBS con-
taining 10 mg/ml ribonuclease (Sigma-Aldrich) and 50 mg/
ml propidium iodide (PI, Sigma-Aldrich) and incubated in
37C in darkness for 40 min. Finally, cells were ﬁltered
through 35 mm pores and 2–5 £ 104 cells were analyzed
using FACSCalibur and CellQuest software.
CFSE staining and ﬂow cytometry analysis
CellTrace CFSE Cell Proliferation Kit (Invitrogen) was used
for analysis of ESCs and MEFs proliferation. Brieﬂy, ESCs
collected after pre-plating or MEFs treated with 0.05% tryp-
sin-EDTA were suspended in 0.1% bovine serum albumin
(BSA, Sigma) in PBS containing 20 mM CFSE (carboxy-
ﬂuorescein diacetate, ester). After 10 min incubation in
37C, cold appropriate culture medium was added and cells
were kept on ice for further 5 min. Afterwards, cells were
washed twice in appropriate culture medium and either
immediately collected for FACS analysis or subjected to fur-
ther in vitro culture. ESCs were either cultured (5 £ 104/
cm2) on feeder layer or in hanging drops to form EBs.
MEFs were plated in density of 4 £ 104/cm2. ESCs (after 1
or 2 d of culture), EBs (after 1 or 2 d of culture), and
MEFs (after 3 d of culture) were trypsynized, washed 2 times
in PBS, and ﬁxed in 3% paraformaldehyde (PFA, Sigma) for
10 min. After further 3 washes in PBS cells were analyzed
using FL1 detector at FACSCalibur (Becton Dickinson) and
CellQuest software (Becton Dickinson). Control cells, that
served as negative control, i.e. those that were not stained
with CFSE, were characterized by the lowest ﬂuorescence
level. They represent cells that underwent many divisions
what resulted in the loss of ﬂuorescence. Cells collected for
analysis immediately after CFSE staining were positive con-
trol as non-divided ones.
Immunolocalization
ESCs, EB outgrowths, and MEFs plated and cultured at cover-
slips were washed 3 times in PBS and ﬁxed in 3% PFA for
10 min. After another 3 washes in PBS ESCs and EB out-
growths were incubated in 0.5% Triton X100 (Sigma-Aldrich)
in PBS for 5 min, and MEFs were incubated in 0.05% Triton
X-100 in PBS for 3 min. Next, cells were washed in PBS and
incubated in 3% BSA in PBS for 1 h. Afterwards, incubation
with primary antibodies solutions was conducted in 4C over-
night. Primary antibodies against Ki-67 (ab15580, Abcam) and
g-H2A.X (ab22551, Abcam), Pax7 (DSHB) were used, diluted
1:500 (Ki-67 and g-H2A.X) or 1:100 (Pax7) in 0.5% BSA in
PBS. Next, cells were washed 3 times in PBS and incubated in
solution containing appropriate secondary antibodies conju-
gated with AlexaFluor594 (Molecular Probes, diluted 1:200)
and DRAQ5 (Biostatus, diluted 1:1000) in 0.5% BSA in PBS for
2 h. Specimens were washed 3 times in PBS and mounted using
Fluorescent Mounting Medium (Dako). Speciﬁcity of primary
antibodies was conﬁrmed by incubation of ESCs, EB out-
growths, and MEFs with secondary antibodies only. The speci-
mens were analyzed using Axiovert 100M scanning confocal
microscope (Zeiss) equipped with LSM 510 software.
Western blotting
Protein extracts were produced by homogenization and lysis of
in vitro cultured ESCs, EBs, EB outgrowths, asynchronously
dividing MEFs, and whole 13.5-day-old mouse embryos.
Brieﬂy, cells and embryos were homogenized and lysed in ELB
buffer containing protease inhibitors (Complete, Roche) and
obtained lysates were kept on ice for 30 minutes, microcentri-
fuged and stored at ¡80C. Protein concentration was deter-
mined by using the Bradford’s assay (Sigma). Twenty mg of
protein was subjected to 12% SDS-PAGE and Western-blot
analysis and probed with antibodies against cyclin E (sc-481,
Santa Cruz Biotechnology), Pax7 (ARP32742, Aviva Systems
Biology) or Hsp90 (TA500494, Origene). As secondary anti-
bodies goat anti-mouse (170-6516, Bio-Rad) or goat anti-rabbit
HRP conjugate (170-6515, Bio-Rad) were used, followed by
chemiluminescence detection. Films were photographed and
optical density of resulting bands was measured using
GelDocXRC (Bio-Rad) with ImageLab software.
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